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Helicobacter pylori does not encode the classical DsbA/DsbB oxidoreductases that are
crucial for oxidative folding of extracytoplasmic proteins. Instead, this microorganism
encodes an untypical two proteins playing a role in disulfide bond formation –
periplasmic HP0231, which structure resembles that of EcDsbC/DsbG, and its redox
partner, a membrane protein HpDsbI (HP0595) with a β-propeller structure. The aim of
presented work was to assess relations between HP0231 structure and function. We
showed that HP0231 is most closely related evolutionarily to the catalytic domain of
DsbG, even though it possesses a catalytic motif typical for canonical DsbA proteins.
Similarly, the highly diverged N-terminal dimerization domain is homologous to the
dimerization domain of DsbG. To better understand the functioning of this atypical
oxidoreductase, we examined its activity using in vivo and in vitro experiments. We found
that HP0231 exhibits oxidizing and chaperone activities but no isomerizing activity, even
though H. pylori does not contain a classical DsbC. We also show that HP0231 is
not involved in the introduction of disulfide bonds into HcpC (Helicobacter cysteine-rich
protein C), a protein involved in the modulation of the H. pylori interaction with its host.
Additionally, we also constructed a truncated version of HP0231 lacking the dimerization
domain, denoted HP0231m, and showed that it acts in Escherichia coli cells in a DsbB-
dependent manner. In contrast, HP0231m and classical monomeric EcDsbA (E. coli
DsbA protein) were both unable to complement the lack of HP0231 in H. pylori cells,
though they exist in oxidized forms. HP0231m is inactive in the insulin reduction assay
and possesses high chaperone activity, in contrast to EcDsbA. In conclusion, HP0231
combines oxidative functions characteristic of DsbA proteins and chaperone activity
characteristic of DsbC/DsbG, and it lacks isomerization activity.
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Introduction
In many Gram-negative bacteria, the periplasmic space is the
major site for the maturation of proteins that enter this
compartment. The three-dimensional structure of proteins is
crucial for their function and stability. The proper folding of
secreted proteins containing cysteine residues, especially those
with an even number of cysteines, often requires the oxidation
of thiol groups between two cysteine residues and the formation
of a covalent bond. Several excellent reviews about functioning
of the Escherichia coli Dsb system have recently been published
(Kadokura and Beckwith, 2010; Depuydt et al., 2011; Berkmen,
2012; Denoncin and Collet, 2013; Hatahet et al., 2014).
In E. coli and other Gram-negative bacteria, the extracyto-
plasmic generation of disulﬁde bonds is catalyzed by disulﬁde
oxidoreductases referred to as DsbAs. These proteins are usually
periplasmic, monomeric, soluble proteins that structurally belong
to the thioredoxin-superfamily. EcDsbA (a 21-kDa monomeric
protein) directly donates its disulﬁde bond present in the active
site to unfolded, reduced protein substrates (Paxman et al., 2009).
A strictly conserved CXXC catalytic motif (CPHC in EcDsbA)
present within the TRX (thioredoxin) fold is required for activity
as well as a proline residue, always found in cis-conformation.
The loop region containing the cis-proline residue, although
distant from the CXXC active site in the linear sequence but close
in the three-dimensional structure, is important for maintaining
both the conformation of the active site and the redox potential
of the protein (Kadokura et al., 2005; Ren et al., 2009). EcDsbA
activity is dependent on the action of the inner membrane
protein DsbB, which restores it to the original, oxidized form.
Classical EcDsbB, protein with four transmembrane segments,
encompasses two pairs of conserved, catalytic cysteine residues
located in the periplasmic loops. The process depends on the cell
respiratory chain (Inaba, 2008).
The action of DsbA is an error-prone process because
DsbA preferentially introduces disulﬁde bonds between cysteines
that are consecutive in the primary sequence of the protein
(Inaba, 2010). Thus, the proteins whose proper folding requires
the formation of disulﬁde bonds between cysteines that are
non-consecutive in the sequence often end up misoxidized
and misfolded. In E. coli, the periplasmic protein disulﬁde
isomerase EcDsbC is responsible for the rearrangement of those
incorrect disulﬁdes, which is crucial for production of non-
consecutive multi-disulﬁde-bonded proteins in the periplasm.
EcDsbC is a 23.3 kDa protein that folds into a V-shaped
homo-dimer (McCarthy et al., 2000). Each monomer of DsbC
consists of two domains: a C-terminal catalytic domain adopting
a thioredoxin fold and an N-terminal dimerization domain
that also plays a role in substrate binding. The C- and
N-terminal domains are connected via a long alpha-helical
linker. The amino-terminal cysteine pairs, which are part of
the active site CXXC motif of EcDsbC, are maintained in
their reduced state by the inner membrane protein DsbD.
EcDsbD, is responsible for maintaining the amino-terminal
cysteine pairs of the EcDsbC in their reduced state. EcDsbD
consisting of three domains catalyzes the transfer of electrons
from the cytoplasm to the periplasm. The electrons ﬂow
from cytosolic NADPH via thioredoxin 1 (Trx1) and then via
the β, γ, and α domains of DsbD to the EcDsbC (Katzen and
Beckwith, 2000; Collet et al., 2003; Stirnimann et al., 2006a,b).
Some microorganisms also possess the inner membrane protein
CcdA, which is a functional homolog of DsbD and only consists
of the β transmembrane domain of DsbD. In contrast to
DsbD, which transfers reducing potential to a large numbers
of extracytoplasmic proteins (Cho and Collet, 2013), CcdA is
thought to be only involved in the cytochrome c maturation
process (Katzen et al., 2002). However, recently published
data, have shown that in Bacillus subtilis, B. anthracis, and
Streptococcus pneumoniae CcdA plays a role also in sporulation
and virulence (Erlendsson et al., 2004; Han and Wilson, 2013;
Saleh et al., 2013).
An extensive bioinformatic screening for DsbA homologs,
combines with recently carried out numerous functional and
structural studies of DsbAs documented an enormous diversity
of the pathways of disulﬁde bond formation within the bacterial
kingdom. For instance, certain bacteria possess multiple DsbAs
with diﬀerent substrate speciﬁcities cooperating with one DsbB,
while some others possess DsbA homologs but lack a homolog
of DsbB. In this latter case, DsbA is reoxidized by a protein
with DsbB-like activity and which is the bacterial homolog
of the vitamin K epoxide reductase (VKOR; Li et al., 2010;
Landeta et al., 2015). DsbA homologs from diﬀerent organisms
display very low overall sequence identity (15–40%) and various
biochemical characteristics as reviewed by Shouldice et al. (2011)
and McMahon et al. (2014). The comparative analysis of their
structural and biochemical features allowed to recognize two
main DsbAs classes (McMahon et al., 2014).
Recently published data, have shown that certain bacteria
encode Dsb proteins involved in disulﬁde bond formation
but fold into a V-shaped homodimeric molecule similar to
EcDsbC. These bacteria include Gram–negative species, such as
Helicobacter pylori or Legionella pneumophila, as well as Gram-
positive organisms like Corynebacterium diphteriae. Even though,
the dimeric DsbAs have been shown to play an important role
in the correct folding of virulence factors, they still remain
poorly characterized when compared to monomeric DsbAs.
Preliminary data indicate that these dimeric enzymes that are
capable of disulﬁde bond formation vary greatly in their catalytic
motifs, structure and biochemical properties (Daniels et al., 2010;
Roszczenko et al., 2012; Kpadeh et al., 2013).
HP0231 (DsbK) is a dimeric oxidoreductase that was
previously described by our research group as a major
oxidoreductase of H. pylori (Roszczenko et al., 2012) and recently
characterized by Lester et al. (2015). Its structure has been solved
by Yoon et al. (2011). HP0231 acts as periplasmic oxidase in
H. pylori and E. coli cells, despite its structural resemblance to
EcDsbG. However, its catalytic CXXC motif is identical to that
of EcDsbA (i.e., CPHC) and diﬀers from that of EcDsbC/G
(i.e., CGYC/CPYC). The cis-Pro loop of HP0231, which is also
necessary for disulﬁde bond formation, is VcP as in EcDsbA.
Here we report a further detailed characterization of HP0231 by
(1) conducting a phylogenetic analysis of HP0231, (2) exploring
the functioning of HP0231 in vivo and in vitro and (3) analyzing
the biochemical, functional and structural features of a truncated
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form of HP0231 lacking the dimerization domain (denoted
HP0231m).
Materials and Methods
Bacterial Strains, Primers, Plasmids, Media,
and Growth Conditions
Bacterial strains, plasmids and primers used in this study
are listed in Tables 1 and 2. More extensive table of strains
is included as Supplementary Table S1. H. pylori strains
(26695 and N6) were grown on Blood Agar base no. 2
(BA) plates (Merck) supplemented with 10% (v/v) horse
blood and OxoidTM Helicobacter pylori Selective Supplement
(Dent) (ThermoScientiﬁc) or Mueller Hinton Broth (MH)
supplemented with 10% (v/v) Fetal Bovine Serum (FBS;
Lonza) at 37◦C under microaerobic conditions provided
by Anoxomat Mark II OP (MART Microbiology B.V) or
CampyGen (ThermoScientiﬁc). For the selection of H. pylori
N6 hp0231::cat complemented strains, kanamycin (25 μg
ml−1) or/and chloramphenicol (10 μg ml−1) were added to
the growth media. The H. pylori N6 hp0231::cat was employed
for complementation experiments by HP0231 and HP0231m
or EcDsbA. E. coli strains were grown at 37◦C on solid
or liquid Luria-Bertani (LB) medium or on M63 minimal
medium (Hiniker et al., 2005). When needed, media were
supplemented with antibiotics at the following concentrations:
100 μg ml−1 ampicillin, 30 μg ml−1 kanamycin, and 20 μg
ml−1 chloramphenicol. The E. coli strains JCB816 (wt), JCB817
(dsbA::kan) and JCB818 (dsbAB::kan; Bardwell et al., 1991),
PL263 (mdoGdsbC::kan), PL284 (mdoGdsbC::kan/pBAD33),
PL285 (mdoGdsbC::kan/dsbC+ ; Leverrier et al., 2011) were
employed for complementation experiments by HP0231 and
HP0231m.
General DNA Manipulations
Standard DNA manipulations were carried out as described
in the Sambrook manual (Sambrook and Russel, 2001) or
according to the manufacturer’s instructions. Polymerase chain
reactions (PCR) were performed with PrimeStar HS DNA
Polymerase (Takara) under standard conditions according to the
manufacturer’s instructions. Synthetic oligonucleotides synthesis
and DNA sequencing were performed by Genomed S.A.,
Warsaw, Poland.
Construction of the Complementation Vector
Carrying hp0231m
The vector carrying hp0231m was constructed by a two-step
PCR method. Brieﬂy, primers HP231_BamL and HP231_katR
were used to amplify the DNA region encoding promoter region
of the hp0231 gene with a native signal sequence (SS) from
the chromosome of H. pylori 26695. The catalytic domain
of the hp0231 gene, including the active motif CXXC, was
ampliﬁed by HP231_katL and HP231_XhoR primers, also from
the chromosome of H. pylori 26695. The HP231_katL and
HP231_katR primers contained 5′ leader nucleotide sequences
complementary to each other. Each PCR product was puriﬁed by
a Gel-Out extraction kit (A&A Biotechnology). Next a mixture of
two puriﬁed products (in equal amounts) was used as a template
in a single PCR reaction, using the primers HP231_BamL and
HP231_XhoR. Subsequently, the resulting PCR product was
puriﬁed and cloned into pGEM-T Easy, generating pUWM568.
Finally, using BamHI and XhoI restriction enzymes, the 1.5 kb
DNA region encoding hp0231m was transferred into pHel2
and pHel3, generating pUWM575 and pUWM574, respectively.
Correct construction of the resulting plasmids was veriﬁed by
sequencing. Production of a proper protein was conﬁrmed by
Western-blot using anti-HP0231 serum.
Construction of the Complementation Vector
Carrying EcdsbA
First, to test if the EcdsbA promoter sequences would be active
in H. pylori cells, a derivative of the shuttle vector pHel3 coding
native EcdsbA was constructed, but the expression of EcDsbA in
H. pylori N6 hp0231::cat cells was undetectable (Western-blot).
Therefore, EcdsbA was cloned under the promoter of the hp0231
gene. Brieﬂy, primers HP231_BamL and 231prom_DsbAR were
used to amplify the DNA region encoding the promoter
region of the hp0231gene from the chromosome of H. pylori
26695. DsbA_231promL and EcDsbA_R2 were used to amplify
the region encoding the EcdsbA gene, including its own SS
from the chromosome of E. coli TG1. The 231prom_DsbAR
and DsbA_231promL primers contained 5′ leader nucleotide
sequences complementary to each other. Each PCR product was
puriﬁed by a Gel-Out extraction kit (A&A Biotechnology). Next,
a mixture of the two puriﬁed products (in equal amounts) was
used as a template in a single PCR reaction, using the primers
HP231_BamL and EcDsbA_R2. Subsequently, the resulting PCR
product was puriﬁed and cloned into pGEM-T Easy to generate
pUWM569. Finally, using BamHI and XhoI restriction enzymes,
the 1.3 kb DNA region encoding EcDsbA was transferred
into pHel2 and pHel3, generating pUWM571 and pUWM570,
respectively. Correct construction of the resulting plasmids was
veriﬁed by sequencing. Production of the proper protein was
conﬁrmed by Western-blot, using anti-EcDsbA serum.
Natural Transformation of H. pylori
The naturally competent H. pylori N6 hp0231::cat and H. pylori
N6 HpdsbI::aph (hp0595) were mixed with appropriate
plasmid DNA and grown on BA plates supplemented with
chloramphenicol or kanamycin as previously described
(Roszczenko et al., 2012).
Protein Analysis
Overexpression and Purification of HP0231 and
HP0231m
HP0231 was overexpressed by autoinduction from an E. coli
Rosetta/pUWM525 (KBO2044) strain and puriﬁed as previously
described (Roszczenko et al., 2012). The HP0231m expression
vector was constructed by amplifying the region encoding the
mature catalytic domain of HP0231m (amino acids 119–265)
with primers 231expIa and 231expII with chromosomal DNA of
H. pylori 26695 used as a template. For cloning the insert into
pET28a and to create the HP0231m-His6 recombinant protein,
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TABLE 1 | Strains and plasmids used in this study.
Name Relevant characteristics Source
H. pylori strains
N6 H. pylori wild-type Behrens et al., 2012
PR378 N6 hp0231::cat Roszczenko et al., 2012
PR397 N6 hp0231::cat/pUWM397 (hp0231+ in trans) Roszczenko et al., 2012
KBO570 N6 hp0231::cat/pUWM570 (EcdsbA+ in trans under native
hp0231 promoter)
This study
KBO574 N6 hp0231::cat/pUWM574 (hp0231m+ in trans) This study
PR305 N6 dsbI::aph Roszczenko et al., 2012
KBO571 N6 dsbI::aph/pUWM571 (EcdsbA in trans under native
hp0231 promoter)
This study
KBO575 N6 dsbI::aph/pUWM575 (hp0231m+ in trans) This study
Escherichia coli strains
BL21/EcdsbA+ BL21 carrying pET28a/EcdsbA JFC collection
BL21/EcdsbC+ BL21 carrying pET28a/EcdsbC JFC collection
BL21/EcdsbG+ BL21 carrying pET28a/EcdsbG JFC collection
KBO2030 Rosetta carrying pUWM591(hp0231m+ ) This study
KBO2044 Rosetta carrying pUWM525 (hp0231) This study
KBO519 JCB816 carrying pHel2 This study
PR501 JCB817 carrying pHel2 Roszczenko et al., 2012
PR521 JCB818 carrying pHel2 Roszczenko et al., 2012
KBO523 JCB819 carrying pHel2 This study
KBO520 JCB816 carrying pUWM500 (HP0231+ in trans) This study
PR503 JCB817 carrying pUWM500 (HP0231+ in trans) Roszczenko et al., 2012
PR522 JCB818 carrying pUWM500 (HP0231+ in trans) Roszczenko et al., 2012
KBO524 JCB819 carrying pUWM500 (HP0231+ in trans) This study
KBO576 JCB817 carrying pUWM575 (HP0231m+ in trans) This study
KBO586 JCB818 carrying pUWM575 (HP0231m+ in trans) This study
PL284 PL263 (mdoGdsbC::kan) carrying pBAD33 Leverrier et al., 2011
PL285 PL263 carrying JFC355 (dsbC+ in trans) Leverrier et al., 2011
KBO2087 PL263 carrying pUWM500 (HP0231+ in trans) This study
KBO2088 PL263 carrying pUWM575 (HP0231m+ in trans) This study
Plasmids
pUWM389 hp0231+ in pGEM T-Easy Roszczenko et al., 2012
pUWM397 hp0231+ in pHel3 Roszczenko et al., 2012
pUWM500 hp0231+ in pHel2 Roszczenko et al., 2012
pUWM574 hp0231m+ in pHel3 This study
pUWM575 hp0231m+ in pHel2 This study
pUWM570 EcdsbA+ in fusion with promoter of hp0231 gene in pHel3 This study
pUWM571 EcdsbA+ in fusion with promoter of hp0231 gene in pHel2 This study
pUWM525 hp0231+ in pET28a Roszczenko et al., 2012
pUWM2029 hp0231m+ in pET28a This study
pET28a/EcdsbA EcdsbA+ in pET28a JFC collection
pET28a/EcdsbC EcdsbC+ in pET28a JFC collection
pET28a/EcdsbG EcdsbG+ in pET28a JFC collection
NcoI and XhoI restriction enzymes were used to yield plasmid
pUWM591. For crystallization and biochemical experiments,
the protein was expressed and puriﬁed from E. coli Rosetta
harboring pUWM591 (KBO2030 strain). Expression was induced
by 0.5 mM IPTG at OD600 ∼0.6. After 18 h in 18◦C, cultures
were centrifuged (4000 g) and the cell pellet was suspended
in 50 mM sodium phosphate, pH 8.0, 300 mM NaCl, 10 mM
imidazole. Cells were disrupted by ultrasonication. The cell lysate
was centrifuged (8000 g) and the resulting supernatant was
applied onto Bio-Scale Mini Proﬁnity IMAC Cartridges (Bio-
Rad) containing Ni-charged resin. The protein was eluted with an
imidazole gradient, using the NGC chromatography system (Bio-
Rad). To obtain higher purity, HP0231 and HP0231m proteins
were next loaded onto ENrichTM SEC 70 size exclusion columns
(Bio-Rad) and eluted with PBS or 50 mM Tris pH 7.5, 150 mM
NaCl, respectively. For biochemical tests, samples were dialyzed
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TABLE 2 | Primers used in this study.
Name Sequence 5′–3′ Orientation Restriction site
HP231_BamL GTGGGATCCGCCTGCTCTTCATCAATAACTTTAG Forward BamHI
HP231_XhoR TACTCGAGCTTGTGGGGATTTGTAGGTC Reverse XhoI
HP231_katR CAATTTCGCGCTATTTTGGTCATTAGCTGAAAC Reverse 
HP231_katL GTTTCAGCTAATGACCAAAATAGCGCGAAATTG Forward 
DsbA_231promL GAACTTTAGGAGTTTTAATGAAAAAGATTTGGCTG Forward 
231prom_DsbAR CAGCCAAATCTTTTTCATTAAAACTCCTAAAGTTC Reverse 
EcDsbA_R2 GTACTCGAGCGGCTAACGCAACAATAACAC Reverse XhoI
231expIa GAGGCCATGGCTAATGACCAAAATAGCGCG Forward NcoI
231expII GTGCTCGAGTGCCTTATAATGGTATAAGAA Reverse XhoI
HcpC_N6_XhoI_down CGCTCGAGAACTTTGATTTTGAGCTGCTTGAGAATATCG Reverse XhoI
HcpC_N6_NcoI_up GCACCCATGGCAGAGCAAGACCCTAAA Forward NcoI
on desalting columns (Bio-Rad) against phosphate buﬀer, pH
7.0 (insulin test) or PBS buﬀer (oxidative and refolding tests of
RNaseA) and concentrated as needed (Amicon R© Ultra-4, 10,000
NMWL; Millipore).
Overexpression and Purification of EcDsbA, EcDsbC,
and EcDsbG
These three E. coli proteins were overexpressed from E. coli BL21
harboring pET28a/EcDsbA, EcDsbC or EcDsbG (JFC lab) by
autoinduction (Studier, 2005) or IPTG induction (Roszczenko
et al., 2012), and then puriﬁed by aﬃnity chromatography and
dialyzed against PBS or phosphate buﬀer, as described above for
HP0231. All proteins were later used in biochemical experiments.
EcDsbA was also used for rabbit immunization (Animal Facility,
Faculty of Biology, University of Warsaw). The anti-EcDsbA
rabbit serum was speciﬁc and recognized native EcDsbA, as
veriﬁed by Western-blot analysis.
Overexpression and Purification of HcpC
The HcpC expression vector was constructed by amplifying
the region encoding the mature catalytic domain of HcpC
(amino acids 24–290) with primers HcpC_N6_XhoI_down and
HcpC_N6_NcoI_up. Chromosomal DNA of H. pylori N6, was
used as a template. For cloning the insert into pET39b and
to create the EcDsbA-HcpC-His6 recombinant protein, NcoI
and XhoI restriction enzymes were used to yield plasmid
pUWM2021. The protein was expressed and puriﬁed from E. coli
Rosetta harboring pUWM2021 (RG2022 strain), as described
above for HP0231. Recombinant protein was used for rabbit
immunization (Animal Facility, Faculty of Biology, University
of Warsaw). The anti-HcpC rabbit serum was speciﬁc and
recognized native HcpC, as veriﬁed by Western-blot analysis.
Preparation of Subcellular Fractions
Subcellular protein fractions were prepared from 48-h H. pylori
cultures. Periplasmic proteins were released from the cells
using an osmotic-shock procedure (Myers and Kelly, 2005).
After decanting the periplasmic fraction, bacterial pellets were
resuspended in 20 mM Tris-HCl, pH 7.5 and sonicated to release
the cell contents. Subsequently, cell wall debris was removed and
the supernatants were ultracentrifuged (100 000 g, 4◦C, 30 min)
to separate the membrane and cytoplasmic fractions. Finally, the
cell envelope was fractionated into inner and outer membranes
by selective solubilization of the inner membrane with 2.0% (w/v)
sodium lauryl sarcosine (Baik et al., 2004).
Biochemical Assays
Determination of the in vivo Redox State of Proteins
The redox states of EcDsbA, HP0231, HP0231m, and HcpC
were visualized by alkylating the free cysteine residues using
4-acetamido-4′-maleimidylstilbene-2,2′-disulfonic acid (AMS,
Invitrogen) as described previously (Roszczenko et al., 2012;
Denoncin et al., 2013).
Alkaline phosphatase (AP) assay
The ability of HP0231m to restore the activity of AP in vivo
in E. coli cells was determined in minimal medium M63 as
previously described (Roszczenko et al., 2012).
Insulin Reduction Assay
Reductase activity was assessed by an insulin precipitation assay
(Bardwell et al., 1991; Kpadeh et al., 2013) using human insulin
solution (Sigma). Reactions (triplicate) were carried out in 200μl
of 100 mM sodium phosphate buﬀer, pH 7.0, 131 μM insulin,
1 mM dithiothreitol (DTT), 2 mM EDTA, and 10 μMHP0231m
or EcDsbA; reaction mixtures were incubated in a 96-well plate
format at room temperature in a SunriseTM (Tecan) plate reader.
Reactions were started by adding DTT to a ﬁnal concentration
of 1 mM. The changes in the absorbance (A650) as a function
of time were measured (Collet et al., 2003; Kpadeh et al., 2013).
The results are presented as the average of three independent
experiments.
Chaperone Activity of HP0231 and HP0231m
The chaperone activity of HP0231 and HP0231m, in comparison
to EcDsbG, was determined as described previously (Shao et al.,
2000) using thermal aggregation of citrate synthase – CS (Sigma)
and luciferase – LUC (Sigma) as chaperone substrate proteins.
Brieﬂy, reactions (triplicate) were carried out in 2 ml of 40 mM
HEPES, pH 7.5, 0.15 μM CS or 0.4 μM LUC and 0.15 μM (for
CS) or 0.2 μM (for LUC) HP0231 or 0.2 μM HP0231m, or with
0.2 μM EcDsbG as a positive control and BSA as a negative
Frontiers in Microbiology | www.frontiersin.org 5 October 2015 | Volume 6 | Article 1065
Bocian-Ostrzycka et al. Features of H. pylori HP0231 oxidoreductase
control, all at 43◦C. Protein aggregation was monitored with light
scattering measurements, using a Varian spectroﬂuorometer. The
excitation and emission wavelengths were set to 350 nm for
measurements when LUC served as a substrate protein and to
500 nm when CS served as a substrate protein. The excitation
and emission slit widths were set to 2.5 nm. Three independent
experiments were performed.
Determination of the Redox Potential of HP0231m
The redox potential of HP0231m was ﬂuorometrically
determined from the equilibrium constant with glutathione, as
previously described (Roszczenko et al., 2012). The results are
presented as the average of three independent experiments.
Oxidative Folding of Reduced RNaseA
In vitro oxidative folding of reduced RNaseA was performed with
HP0231, HP0231m, and EcDsbA as described earlier, with a few
modiﬁcations (Daniels et al., 2010; Chim et al., 2013). Proteins
were oxidized with 50 mM oxidized glutathione (GSSG) and
incubated for 1 h at room temperature. RNaseA was reduced
by overnight incubation at room temperature in 100 mM Tris
acetate pH 8.0, containing 6 M guanidine hydrochloride and
140 mM DTT. All proteins were then dialyzed on desalting
columns (Bio-Rad) and concentrated in PBS. Native RNaseA
and EcDsbA were used as positive controls. The redox state
of the thiols was conﬁrmed by the Ellman’s assay, which
exploits the colorimetric change at A412 when 5,5′-dithio-bis-
(2-nitrobenzoic acid) (DTNB; ThermoScientiﬁc) is converted to
2-nitro-5 thiobenzoate (TNB) upon cleavage of the disulﬁde bond
by free thiols. Oxidase activity was measured by analyzing the
cleavage of cCMP (Sigma; cytidine 2′:3′-cyclic monophosphate
monosodium salt) at A296 by refolded RNaseA in the presence of
tested enzymes. Reactions (triplicate) were carried out in 200 μl
of PBS buﬀer containing 100 mM Tris acetate pH 8.0, 2 mM
EDTA, 0.2 mM GSSG, 1 mM GSH, 4.5 mM cCMP, RNaseA
(10 μM) and analyzed enzyme (20 μM). The reaction mixtures
were prepared in a 96-well plate format and read through 30 min
at 27◦C in a SunriseTM (Tecan) plate reader. Three independent
experiments were performed.
Refolding of Scrambled RNaseA (scRNase)
In vitro refolding of scrambled RNaseA was performed for
HP0231, HP0231m, and EcDsbC as described earlier, with a
few modiﬁcations (Messens et al., 2007; Daniels et al., 2010;
Chim et al., 2013). Proteins were reduced with 100 mM DTT
and incubated overnight at 4◦C. RNaseA was ﬁrst reduced
by overnight incubation at room temperature in 100 mM
Tris acetate pH 8.0, containing 6 M guanidine hydrochloride
and 140 mM DTT. Then, in order to introduce incorrect
disulﬁdes, the reduced RNaseA was dialyzed against PBS buﬀer
containing 6 M guanidine hydrochloride, sparged with oxygen
and incubated for 3 days in the dark at room temperature. Finally,
2 mM hydrogen peroxide (Sigma) was added for 30 min at 25◦C.
All proteins were then dialyzed on desalting columns (Bio-Rad)
and concentrated in PBS. Native RNaseA and EcDsbC were used
as a positive control. The redox state of the thiols was conﬁrmed
by the Ellman’s assay. RNaseA activity was measured by analyzing
the cleavage of cCMP, as described above for the oxidative test,
but with the reaction mixture changed to 100mMTris acetate pH
8.0, 2 mM EDTA, 10 μM DTT, 4.5 mM cCMP, RNaseA (40 μM)
and analyzed enzyme (20 μM). Three independent experiments
were performed.
Phenotype Assays
Spot Titers for Cadmium Resistance
Spot titers for cadmium resistance were performed to quantify
the relative oxidase activity of HP0231m in vivo (Ren et al., 2009).
Brieﬂy, H. pylori cells were harvested from BA plates after 24 or
48 h of incubation under microaerobic conditions. Samples were
standardized using OD600nm of the culture and serially diluted
with 150 mM NaCl. Then, 4 μl of each dilution was plated
onto BA plates, supplemented with 8–12 μM cadmium chloride.
H. pylori cells were incubated 5–7 days under microaerobic
conditions. All spot titers were performed in triplicate.
Motility Assays
Helicobacter pylori cells were harvested from BA plates after 24
or 48 h of incubation under microaerobic conditions. Samples
were standardized using OD600nm of the culture. Next, cells
were inoculated with a sterile toothpick onto Mueller-Hinton
(MH) soft agar plates containing 0.35% (w/v) agar and 10% (v/v)
FCS, and incubated for 4–5 days at 37◦C under microaerobic
conditions. E. coli cells were grown in liquid culture in LB broth
until the OD600nm value was 0.6. Then bacteria were inoculated
with a sterile toothpick onto LB soft agar plates containing 0.35%
(w/v) agar and incubated overnight at 37◦C. All motility assays
were performed in triplicate.
Bioinformatics Analyses
In proteins HP0231, LpDsbA2, EcDsbG, EcDsbA, Cj1380,
CG_0026, and CG_2799, the sequences corresponding to the
thioredoxin catalytic domains were deﬁned using an on-line
version of HHpred (Biegert et al., 2006). These sequences were
subsequently used as queries for PSI-BLAST searches (three
iterations) on nr90 database (NCBI non-redundant protein
sequence database ﬁltered at 90% sequence identity). The
matching sequences obtained from the individual PSI-BLAST
runs were grouped together, and redundant, poorly matching
(e-value > 1e−3) and truncated (query coverage < 90%)
sequences were removed. The ﬁnal set of 6181 sequences was
clustered according to the pair-wise sequence similarity using
CLANS (Frickey and Lupas, 2004; p-value cut-oﬀ 1e−11) and
the clusters corresponding to HP0231, DsbG, DsbC, and class I
and class II DsbA were deﬁned manually. Additionally, a sub-
cluster of the class II DsbA cluster, containing the sequence of the
catalytic domain of the LpDsbA2 protein, was deﬁned. Multiple
sequence alignments of sequences contained in the individual
clusters were built with MUSCLE (Edgar, 2004) and used to
calculate sequence logos with WebLogo (Crooks et al., 2004).
For each of 6181 catalytic domain sequences, an upstream
region (i.e., from the N-terminal end of a protein to the beginning
of the catalytic domain) was extracted. After removing sequences
shorter than 50 amino acids, the remaining 3304 sequences
were searched using a local version of HHpred (Remmert et al.,
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FIGURE 1 | Clustering of Dsb catalytic domain sequences. Points and edges correspond to Dsb catalytic domain sequences and their pair-wise similarities,
respectively. Catalytic domains that contain an upstream dimerization domain (DsbG/C/HP0231-like – red and LpDsbA2-like – green) are indicated. Clusters of
sequences are indicated with dashed boxes and for each cluster CxxX and XcP motifs conservation is shown as sequence logo in which height of a letter
corresponds to the frequency of occurrence of a given amino acid.
2012) and a database of sequence proﬁles corresponding to
the dimerization domains of DsbG/C and HP0231. Moreover,
the sequences were scanned for the presence of coiled-coil
domain motifs, using MARCOIL (Delorenzi and Speed, 2002)
and PCOILS (Lupas et al., 1991). Finally, the sequences were
clustered with CLANS (p-value cut-oﬀ 5e−6) and two clusters
were deﬁned (see Figure 2).
Results
Phylogenetic Analysis of HP0231
To gain insight into theH. pyloriDsb system and the evolutionary
origins of HP0231, we ﬁrst decided to use a phylogenetic
approach by performing sequence clustering analysis of the
thioredoxin catalytic domains of Dsb proteins (see Materials and
Methods for details; Kpadeh et al., 2013, 2015). The resulting
map (Figure 1) revealed two clusters corresponding to type I and
type II DsbA domains, as deﬁned by McMahon et al. (2014). The
type-II DsbA cluster is connected to the DsbC cluster and closely
related to the DsbG cluster. The C-terminal catalytic domain
of the HP0231 protein is localized in a tiny separate cluster,
which is speciﬁcally connected to the DsbG cluster, whereas the
catalytic domain of LpDsbA2, dimeric Dsb bifunctional protein
of L. pneumophila, is localized in the DsbA type-II cluster. The
closest homologs of HP0231 typically contain the CPHC/VcP
motif, which is identical to the one observed in canonical DsbA
proteins. The catalytic domains of the DsbG and DsbC proteins,
despite being closely related to the catalytic domain of HP0231,
typically contain CPYC/TcP and CGYC/TcP motifs, respectively.
The most common motif for LpDsbA2 (L. pneumophila DsbA2
protein) homologs is CGYC/TcP.
In addition to the clustering of the catalytic C-terminal
domains, we performed an analogous analysis with the
N-terminal domain of HP0231. To this end, we extracted
sequences preceding the catalytic domains of Dsb proteins, as
shown in Figure 1, and clustered them with CLANS, a method
that displays the pair-wise sequence similarities measured as
BLAST p-values in form of two-dimensional map. The resulting
map (Figure 2) revealed two large clusters; the ﬁrst contained
sequences homologous to the N-terminal dimerization domains
of DsbG/C proteins, and the second encompassed homologs
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FIGURE 2 | Clustering of dimerization domain sequences. Points and edges correspond to dimerization domain sequences and their pair-wise similarities,
respectively. Dimerization domains that are located upstream DsbG/C/HP0231-like and LpDsbA2-like catalytic domains are shown in red and green, respectively.
Clusters of sequences are indicated with dashed boxes and they correspond to clusters defined in the Dsb catalytic domains cluster map (see Figure 1).
of the N-terminal domain of L. pneumophila DsbA2. The
sequences from the two clusters share no homology and
apparently evolved independently. Analysis of the LpDsbA2
N-terminal domain sequence and its homologs revealed a
putative coiled-coil domain, probably (e-value: 0.022) related
to the zinc resistance-associated protein (pdb: 3lay). The
HP0231 dimerization domain is localized in a separate cluster
related to the DsbG/C dimerization domains. The sequences
on the catalytic domain cluster map (Figure 1) were colored
according to the presence of either the DsbG/C/HP0231-like
dimerization domain (red) or the LpDsbA2-like dimerization
domain (green).
Construction of an HP0231 Derivative Lacking
the Dimerization Domain (HP0231m) and
Analysis of its Oxidoreductase and
Isomerization Activities in vivo
Our recent work (using biochemical and genetic approaches)
led to the characterization of the ﬁrst dimeric oxidoreductase
(HP0231) functioning in an oxidizing pathway in H. pylori. We
also showed that it complemented the lack of DsbA in E. coli
when delivered on a low-copy plasmid (Roszczenko et al., 2012).
To better understand functioning of the H. pylori Dsb
network, we further examined the activity of HP0231 by
performing various in vivo and in vitro experiments. Moreover,
to assess the signiﬁcance of its dimeric structure, we generated
a truncated HP0231 lacking the dimerization domain, denoted
HP0231m. The truncated protein was constructed by cloning
part of the hp0231 gene encoding a catalytic domain in frame
with its native SS, under the control of an original promoter.
For the complementation assays in H. pylori hp0231− or in
E. coli dsbA−/dsbAB− mutants, the DNA fragment encoding
HP0231m was cloned into either pHel3 (pUWM2017) or pHel2
(pUWM2014), respectively (Heuermann and Haas, 1998). We
show in Supplementary Figure S1 how the diﬀerent plasmids
were constructed. Production of the monomeric version of
HP0231 in H. pylori, as well as in E. coli cells, was conﬁrmed by
Western-blot analysis, using speciﬁc rabbit anti-HP0231 serum.
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FIGURE 3 | Size exclusion profiles of the purified Helicobacter pylori
proteins separated on an ENrichTM SEC70 column (Bio-Rad) and
monitored by absorbance at 280 nm. (A) HP0231 elutes as a single peak
at 9.05 min, with an estimated mass of 56 kDa, consistent with the size of the
homodimer. (B) HP0231m elutes at 11.1 min, with estimated mass of 18 kDa,
consistent with the size of the monomer. The column was calibrated with Gel
Filtration Standard (Bio-Rad): Thyroglobulin (670 kDa), γ-globulin (158 kDa),
Ovalbumin (44 kDa), Myoglobin (17 kDa), Vitamin B12 (1.35 kDa). The relative
positions of the chosen standards are marked with arrows.
To verify that HP0231m indeed exists as a monomeric protein,
size exclusion chromatography was employed (Figures 3A,B).
His6-tagged HP0231 and His6-tagged HP0231m puriﬁed from
E. coli cells were applied to calibrated gel ﬁltration column.
HP0231 was eluted as a single peak at 9.05 min, corresponding
to an approximate mass of 56 kDa, which is consistent with its
dimeric structure. In contrast, HP0231m eluted at 11.1 min, with
an approximate mass of 18 kDa, corresponding to a monomeric
structure. We ﬁrst tested whether truncated HP0231m can
complement lack of DsbA in E. coli. Complementation tests
showed that HP0231m was able to restore both motility and
AP activity (Figures 4A,B), as observed with native EcDsbA.
Moreover, the HP0231m activity was fully EcDsbB-dependent,
as judged by its inability to allow bacterial motility or regenerate
AP activity in a double mutated E. coli dsbAB strain. Note that
we previously showed that complementation by dimeric HP0231
does not require DsbB (Roszczenko et al., 2012). In contrast
FIGURE 4 | HP0231m restores the Escherichia coli dsbA::kan wild type
phenotype in a DsbB-dependent manner in two functional assays. As
negative controls, E. coli dsbA::kan and E. coli dsbAB::kan were transformed
with an empty pHel2 vector. (A) Alkaline phosphatase (AP) assay. The bars
represent average activity of three independent experiments (n = 3) with the
wild type set to 100% activity. There are significant differences (p < 0.001) in
relative AP activity between the E. coli wt cells and the E. coli dsbA::kan and
E. coli dsbAB::kan mutant strains, and also the strains complemented in trans
by hp0231 and hp0231m. Error bars marked with asterisk (∗) indicate no
significant difference between dsbAB::kan/pHel2 and dsbAB::kan/hp0231m+
(ANOVA followed by post hoc Tukey’s test). AP activity of wild type and dsb
mutants and complemented strains was performed in M63 minimal medium.
(B) Motility of the E. coli dsbA::kan and E. coli dsbAB::kan complemented in
trans by hp0231 and hp0231m. Bacterial motility was monitored after 24 h of
incubation on 0.35% LB-agar plates. The E. coli dsbAB::kan/hp0231m+ is
non-motile while E. coli dsbA::kan/hp0231m+ and E. coli
dsbAB::kan/hp0231+ are motile. The figure presents a representative result.
to what was observed in E. coli cells, complementation tests in
H. pylori revealed that HP0231m was not able to restore motility
or cadmium resistance – two phenotypes that are defective in
H. pylori hp0231− cells (Figures 5A–C). Also EcDsbA, expressed
from the native hp0231 promoter (pUWM570), was not active
when introduced into H. pylori hp0231−, as measured by the
same tests Supplementary Figure S2.
In order to introduce disulﬁde bonds, DsbA proteins need to
be regenerated by a protein like DsbB that transfers the electrons
to the respiratory chain (Inaba, 2008; Inaba and Ito, 2008). It is
not completely clear how HP0231 is re-oxidized in vivo. H. pylori
does not encode a classical DsbB, although it does encode a DsbB-
like protein – HpDsbI (HP0595). As previously shown, mutation
of the hpdsbI gene produces HP0231 in the reduced form, though
the active, oxidized form remains more pronounced (Roszczenko
et al., 2012). Thus we decided to check whether the HP0231 in
cells that lack HpDsbI is still active. To do this, we performed a
motility test for dsbI mutated cells, which showed that partially
oxidized HP0231 still assures cell movement Supplementary
Figure S3. These results suggest that HpDsbI plays a role in
HP0231 reoxidation but other mechanisms may also be involved.
Helicobacter pylori proteome does not contain the classical
homodimeric DsbC, which in many Gram-negative bacteria
rearranges incorrectly paired cysteines (McCarthy et al., 2000).
Previously we showed that HP0231 does not complement an
EcdsbC mutant as assessed by copper sensitivity (Roszczenko
et al., 2012). Copper is known to catalyze the formation of
non-native disulﬁde bonds in many periplasmic proteins, and
therefore, this assay measures the global eﬀect of EcDsbC activity
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FIGURE 5 | HP0231m is not active in H. pylori hp0231::cat cells. As a positive control, H. pylori N6 hp0231::cat was transformed with pHel2 carrying the native
hp0231 gene. (A,B) cadmium sensitivity assay. Exponentially growing H. pylori (wt, the hp0231::cat mutant and hp0231::cat complemented in trans with hp0231 or
hp0231m). Cultures were 10-fold serially diluted, spotted on BA plates without (A) or with (B) 8 μM CdCl2, and incubated at 37◦C. The mutant shows reduced
growth after 3 days of incubation on plates containing cadmium chloride. HP0231, but not HP0231m, partially restore the cadmium resistance of the H. pylori
hp0231::cat. (C) Motility assay. Bacterial motility was monitored after 4 days of incubation on 0.35% MH-agar plates containing 10% FCS. Both the hp0231::cat
mutated strain and the same strain complemented in trans with hp0231m are non-motile.
(Hiniker et al., 2005). In order to conﬁrm that result in a more
direct manner, we decided to examine HP0231 isomerization
activity by checking its inﬂuence on the structure of a speciﬁc
protein, EcRcsF. EcRcsF is a small outer-membrane lipoprotein
which activates the Rcs phosphorelay upon envelope stress,
and contains two non-consecutive disulﬁde bonds (Cho et al.,
2014). One of them is necessary for proper EcRcsF folding, and
the process of disulﬁde bond formation is EcDsbC dependent.
Mutation of the mdoG gene, involved in the synthesis of
membrane-derived oligosaccharide, activates the Rcs system in
an RcsF-dependent manner. AnmdoGmutant displays a mucoid
phenotype on M63 minimal medium, while a double mdoGdsbC
mutant does not, due to lack of activation of the Rcs cascade
(Leverrier et al., 2011). We examined the ability of HP0231
and HP0231m to complement the deﬁciency of DsbC in an
mdoGdsbC double E. colimutant. We found that neither HP0231
nor HP0231mwas capable of complementing the lack of EcDsbC,
further suggesting that HP0231 cannot function as an isomerase
in a heterologous host, E. coli (Figure 6).
Redox State of HP0231m and HP0231 in E. coli
and H. pylori Cells
HP0231 is present in H. pylori in an oxidized form, which
is consistent with its function (Roszczenko et al., 2012).
Considering that it does also act as an oxidase in E. coli,
we next determined its redox state in E. coli cells. An AMS
trapping experiment showed that HP0231 is present mainly in
the oxidized form, as expected (Figure 7A). A small amount
of HP0231 in the reduced form was detectable, independently
of the genetic background of the host (E. coli dsbA− vs.
E. coli dsbAB−). The extra immunoreactive proteins migrating
faster than the oxidized form of HP0231 are E. coli protein/s
reacting with anti-HP0231 serum, which also are modiﬁed by
AMS. As the activity of HP0231, previously measured by the
AP assay, was also EcDsbB independent, the mechanism of
HP0231 reoxidation in both the native and the heterologous
host still remains unexplained. The dimeric structure of HP0231
appears to be a structural barrier for its potential upstream
redox partner when expressed in E. coli, as monomeric
HP0231m interacts with EcDsbB whereas dimeric HP0231 does
not.
Next, the redox state of HP0231m in H. pylori cells was
determined using the AMS trapping strategy and speciﬁc rabbit
anti-HP0231 serum. We found that HP0231m was present
predominantly in the oxidized form, the absence of HpDsbI
resulting only in the appearance of small amounts of the proteins
in the reduced forms. Also EcDsbA is present in H. pylori in the
oxidized form (Figures 7B,C – the presence of HP0231m in three
forms makes interpretation diﬃcult). Consequently, based on
in vivo experiments, we concluded that the inability of HP0231m
to complement the lack of native HP0231 is probably due to the
lack of dimeric structure.
Biochemical Properties of HP0231m
Compared to Native Dimeric HP0231
In order to further characterize HP0231m, we analyzed
its biochemical properties in comparison to HP0231. The
recombinant proteins used for biochemical analysis were
produced as cytoplasmic proteins in E. coli cells and puriﬁed
by aﬃnity chromatography. First, to gain insight into the
mechanism of HP0231m action, we determined its redox
potential by equilibrating this protein in a series of redox buﬀers
containing various ratios of reduced and oxidized glutathione.
We found that the HP0231m redox potential was −112 mV
Supplementary Figure S4, identical to that previously determined
for HP0231 and similar to that of EcDsbA (Inaba and Ito, 2002;
Roszczenko et al., 2012).
Next, we evaluated the ability of HP0231m to reduce insulin
in the presence of DTT, the assay commonly used to determine
whether a protein functions as an oxidoreductase. Unexpectedly,
although HP0231m complements the lack of EcDsbA in vivo and
its redox potential is similar to that of EcDsbA, it was not active in
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FIGURE 6 | HP0231 and HP0231m cannot function as a reductase in an
mdoGdsbC::kan strain. The E. coli mdoGdsbC::kan strain harboring various
recombinant plasmids (pBAD33, pBAD33/dsbC+ , pHel2/hp0231+ ,
pHel2/hp0231m+ ) were grown on M63 minimal medium for 2 days at room
temperature. The mucoid phenotype of the mdoGdsbC/dsbC+ strain was
observed. Neither hp0231 nor hp0231m complements the dsbC mutation.
this assay (Figure 8A). However, it should be noted that HP0231
catalyzes the insulin reduction evenmore eﬃciently than EcDsbA
(Roszczenko et al., 2012).
We then decided to examine how eﬃciently they oxidize a
protein a substrate in vitro using unfolded RNaseA as substrate
(Figure 8B). We found that all proteins tested (EcDsbA, HP0231,
and HP0231m) reactivated reduced unfolded RNase (ruRNase)
at identical levels. We also examined the isomerization activity
of both H. pylori proteins using scrambled RNase (scRNase) as a
substrate and E. coli DsbC as a positive control. Neither HP0231
nor HP0231m was active in this test (Figure 8C).
Given that HP0231 is a homodimer and the two well-
characterized E. coli homodimeric oxidoreductases (EcDsbC and
EcDsbG) function as molecular chaperones (Shao et al., 2000;
Zhao et al., 2003), we examined whether HP0231 also acts as
molecular chaperone by analyzing its inﬂuence on the thermal
aggregation of two classical chaperone substrate proteins, CS
and LUC. As EcDsbA exhibits low chaperone activity (Zheng
et al., 1997), the monomeric derivative of HP0231 (HP0231m)
was also included in these tests. We found that HP0231 as well
as HP0231m reveal chaperone activity. HP0231 showed activity
similar to dimeric EcDsbG, whereas monomeric HP0231m
prevented the thermal aggregation of substrate proteins even
more eﬃciently than both homodimeric proteins (Figures 8D,E).
HP0231 has recently been described as a folding factor of HcpE
(HP0235; Lester et al., 2015). HcpE potentially contains nine
disulﬁde bonds, as judged from structure modeling based on
the previously solved structure of HcpC (Luthy et al., 2004). It
is still unclear whether HP0231 is involved in the formation of
the HcpE disulﬁde bonds. The authors documented that the lack
of HP0231 resulted in decrease of the amount of HcpE and
showed the interaction between HcpE and HP0231 in in vitro
experiments. However, they did not show that the activity of
HP0231 inﬂuences the redox state of HcpE in vivo. To better
FIGURE 7 | Redox state of HP0231 in E. coli and HP0231m and EcDsbA
in H. pylori. (A) HP0231 in E. coli wt, E. coli dsbA::kan and E.coli dsbAB::kan
strains. Asterisk (∗) mark unspecific bands. (B,C) EcDsbA (B) and HP0231m
(C) in H. pylori N6 dsbI::kan or hp0231::cat mutants. Bacterial cultures were
treated with 10% TCA, followed by alkylation with AMS. Cellular proteins
including the reduced (red; DTT treated, modified with AMS) and the oxidized
(ox; non-modified with AMS) controls were separated by 18% SDS-PAGE
under non-reducing conditions, followed by Western-blot analysis using rabbit
antibodies against HP0231 or EcDsbA. Each lane contains proteins isolated
from the same amount of bacteria.
understand the potential impact of HP0231 on the structure of
Hcp proteins, we evaluated the redox state of another member
of the Hcp family – HcpC. According to the data presented by
Lester et al. (2015), we found that the amount of HcpC present
in H. pylori hp0231 isogenic mutant is reduced as compared
to H. pylori wild type (Figure 9A). However, using the AMS
trapping strategy we showed that the lack of HP0231 potentially
does not inﬂuence the HcpC redox state. Notice that in the AMS
trapping experiment the reduced form of HcpC is not recognized
by speciﬁc antibodies, probably due to the large numbers of AMS
particles bound to reduced form of the HcpC. As a control of the
usedmethodology, we checked the redox state of HP0231 present
in the same bacterial culture (Figures 9B,C). Additionally, the
used strategy does not discriminate between correctly oxidized
and misoxidized protein.
Crystal Structure of HP0231m
It was unexpected that HP0231m was not able to reduce insulin,
even though it was active in vivo in E. coli. Its other distinguishing
biochemical feature, as compared to EcDsbA, is a high chaperone
activity. Thus, the HP0231m structure was solved and compared
to the structures of EcDsbA and MtDsbA (Figures 10A,B). The
HP0231m structure can be superimposed onto the full-length
HP0231 structure (PDB: 3tdg) with an RMSD of 2.1 Å, and
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FIGURE 8 | Biochemical assays performed on purified HP0231 and HP0231m. Purified EcDsbA, EcDsbC, or EcDsbG were used as controls. (A) HP0231m is
not active in the insulin reduction assay. The reaction contained 131 μM insulin in potassium phosphate buffer, pH 7.0 and 2 mM EDTA. The reaction was performed
in the absence or presence of 10 μM EcDsbA and 10 μM HP0231m. Reactions were started by adding DTT to the final concentration of 1 mM. Changes in the
absorbance at 650 nm as a function of time were measured. The figure presents the average of three independent experiments (n = 3). (B) HP0231 and HP0231m
are active in an oxidase activity assay (reduced unfolded – ruRNase activity assay). Reactions were carried out in 200 μl of PBS buffer containing 100 mM Tris
acetate pH 8.0, 2 mM EDTA, 0.2 mM GSSG, 1 mM GSH, 4,5 mM cCMP, ruRNaseA (10 μM) and the analyzed enzyme (20 μM). The reaction was performed in the
absence or presence of 20 μM EcDsbA, 20 μM HP0231, or 20 μM HP0231m. Changes in absorbance at 296 nm as a function of time were measured. Three
independent experiments were performed. The figure presents a representative result. (C) HP0231 and HP0231m cannot work as isomerases in the scrambled
RNase (scRNase) activity assay. Reactions were carried out in 200 μl of PBS buffer containing 100 mM Tris acetate pH 8.0, 2 mM EDTA, 10 μM DTT, 4.5 mM cCMP,
scRNaseA (40 μM) and the analyzed enzyme (20 μM). Reactions were performed in the absence or presence of 20 μM EcDsbC, 20 μM HP0231, or 20 μM
HP0231m. Changes in absorbance at 296 nm as a function of time were measured. Three independent experiments were performed. The figure presents a
representative result. (D) HP0231 and HP0231m suppress the thermal aggregation of luciferase (LUC) in the chaperone activity assay. LUC was diluted to a final
concentration of 0.10 μM into 40 mM HEPES-KOH buffer, pH 7.5, equilibrated at 43◦C in the absence or in the presence of 0.15 μM HP0231 or 0.15 μM
HP0231m, respectively. Protein aggregation was monitored with light scattering measurements using a Varian spectrofluorometer. The excitation and emission
wavelengths were set to 350 nm. The excitation and emission slit widths were set to 2.5 nm. To exclude unspecific protein effects, control experiments in the
presence of 1.5 μM bovine serum albumin were conducted. Three independent experiments were performed. The figure presents a representative result.
(E) HP0231 and HP0231m suppress the thermal aggregation of citrate synthase (CS) at 43◦C. 30 μM CS was diluted 200-fold into prewarmed 40 mM
HEPES-KOH, pH 7.5, at 43◦C in the absence or presence of 0.15 μM HP0231 and 1.5 μM HP0231m, respectively. Protein aggregation was monitored with light
scattering measurements using a Varian spectrofluorometer. The excitation and emission wavelengths were set to 350 nm. The excitation and emission slit widths
were set to 2.5 nm. To exclude non-specific protein effects, control experiments in the presence of 1.5 μM bovine serum albumin were conducted. Three
independent experiments were performed. The figure presents a representative result.
according to Dali Lite searches, it is also very similar. The β1
forms hydrogen bonds to β3, a feature observable in structures of
catalytic domains of DsbG, DsbC, and also in class II DsbA-like
proteins (McMahon et al., 2014). This is in agreement with our
phylogenetic analysis, which showed that the DsbG/C/HP0231
branch is more closely related to class II DsbA-like proteins than
to canonical class I DsbA (Figure 1).
Discussion
The H. pylori HP0231 protein is an oxidoreductase that acts as
a homodimer (Yoon et al., 2011; Roszczenko et al., 2012). So
far, this unique structure for proteins involved in the oxidative
pathway of disulﬁde bond formation has only been described for
L. pneumophila (Kpadeh et al., 2013, 2015) and the Gram-positive
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FIGURE 9 | Interaction between HP0231 and HcpC. (A) Quantitative
Western-blot analysis of HcpC in H. pylori wt and H. pylori hp0231::cat cells.
Each lane contains the same amount of proteins. Samples (native or DTT
treated) were separated by 12% SDS-PAGE under non-reducing conditions,
followed by Western-blot analysis using specific rabbit antibodies against
HcpC. (B,C) Redox state of HP0231 and HcpC in H. pylori cells. Asterisk (∗ )
mark unspecific bands. (B) HcpC in H. pylori wt and H. pylori hp0231::cat.
(C) Control of the used methodology: HP0231 in H. pylori wt and H. pylori
hp0231::cat. Bacterial cultures were treated with 10% TCA, followed by
alkylation with AMS. Cellular proteins including the reduced (red; DTT treated,
modified with AMS) and the oxidized (ox; non-modified with AMS) controls
were separated by 18% SDS-PAGE under non-reducing conditions, followed
by Western-blot analysis using rabbit antibodies against HcpC or HP0231.
Each lane contains proteins isolated from the same amount of bacteria. The
reduced form of HcpC is not recognized by anti-HcpC serum (B) probably due
to the large numbers of AMS particles bound to reduced form of the HcpC.
FIGURE 10 | Structural classification of HP0231 (aa 132–264).
(A) Structure of HP0231. (B) Superposition of HP0231 (gray) and
MtbDsbA (green; pdb:4K6X). The β1 HP0231 strand forms hydrogen bonds
with β3 strand, which classifies it to the DsbA_II group.
C. glutamicum (Daniels et al., 2010). However, apart from the
oxidative function, all the above proteins diﬀer signiﬁcantly in
their structure, CXXC and cis-Pro active sites, and in their
phylogenetic origin. Also, the whole set of Dsb proteins involved
in the oxidative pathway varies, depending on the microorganism
species. L. pneumophila encodes two DsbAs, (monomeric DsbA1
and dimeric DsbA2), as well as two DsbB and two DsbD proteins,
whereas H. pylori lacks both a classical DsbB and a classical
DsbD (Raczko et al., 2005; Kpadeh et al., 2015). The catalytic
domain of HP0231 possesses catalytic motifs typical for canonical
DsbA proteins, but evolutionarily it is most closely related to
the catalytic domains of DsbG (Figure 1). Similarly, the highly
diverged N-terminal dimerization domain is homologous to
the dimerization domain of DsbG (Figure 2). However, in this
case, the sequence similarity is very low (12% over the aligned
region) and the homology relationship could only be conﬁrmed
based on sequence proﬁle–proﬁle comparisons (see Materials
and Methods) and structural similarity (Yoon et al., 2011). The
well-characterized L. pneumophila LpDsbA2, alike HP0231, is
a dimeric protein possessing oxidoreductase activity. It must
be emphasized, however, that the two proteins are unrelated.
First, the catalytic domain of LpDsbA2 belongs to the type
II DsbA class (McMahon et al., 2014), whereas the catalytic
domain of HP0231 originates from DsbG proteins. Second,
the two proteins contain diﬀerent and evolutionarily unrelated
dimerization domains: a coiled-coil domain in LpDsbA2 and a
DsbG/C-like domain in HP0231. Considering that dimerization
domains seem to occur only in the context of the β1 arrangement
observed in HP0231, DsbG/C, and class II DsbA-like catalytic
domains, one can speculate that it might be a prerequisite for the
formation of two-domain Dsb proteins, in which a dimerization
domain precedes the catalytic domain. The combination of
diﬀerent catalytic and dimerization domains are reﬂected in
the protein functions. LpDsbA2 displays both an oxidizing and
an isomerization activity in the native host (L. pneumophila),
which is ensured by concerted action of the LpDsbBs and
LpDsbDs proteins (Kpadeh et al., 2015). Our previous work
and data presented in this paper indicated that in the native
host (H. pylori), HP0231 is an oxidoreductase responsible for
disulﬁde bond formation, as was proven by: evaluating its redox
state, its inﬂuence on cell resistance to DTT (Roszczenko et al.,
2012), cadmium sensitivity, and also conﬁrmed by its ability to
oxidize unfolded, reduced RNaseA (ruRNaseA) in vitro. Recently
published data by Lester et al. (2015) showed that HP0231, as well
as EcDsbA and the EcDsbG used as a control in this experiment,
have a rather weak eﬃciency at refolding denatured, unfolded
lysozyme under standard conditions. However, changing the
reaction conditions resulted in a high oxidizing activity for
HP0231. Previously lysozome has been used to study the
mechanism of action of a eukaryotic protein-disulﬁde isomerase
(PDI), capable of forming and rearranging disulﬁde bonds during
oxidative protein folding. The speciﬁc structure of PDI (two
thioredoxin domains) is responsible for its dual function (Puig
and Gilbert, 1994; Puig et al., 1994). EcDsbG is not active in
the test presented by Lester et al. (2015), as EcDsbG, despite its
dimeric structure that is similar to EcDsbC (the main isomerase
of E. coli), diﬀers fromDsbC by reacting preferentially with folded
proteins (Heras et al., 2004), and it is mainly involved in the
control of the cysteine sulfenylation level, which protects single
cysteine residues from oxidation to sulfenic acid (Depuydt et al.,
2009; Kadokura and Beckwith, 2010).
In E. coli cells, LpDsbA2 is present in the reduced form,
provided by EcDsbD, and functions only as isomerase, whereas
HP0231 in the same background is present in the oxidized
form, acts as oxidase and does not show isomerization activity,
as was proven previously and in this work by in vitro and
in vivo experiments. At this point, it is worthwhile to emphasize
that contrary to L. pneumophila, H. pylori does not encode a
classical DsbD. Instead, it has shortened version of DsbD, CcdA
(Cho et al., 2012). Thus, HP0231 is potentially not capable of
interacting with EcDsbD.
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Our recently performed in vitro experiments identiﬁed
apocytochrome c (HP1227) as HP0231 substrate (Roszczenko
et al., 2015). Oxidative folding potentially protects
apocytochrome c from degradation. However, the cytochrome c
maturation process required ligation of heme to reduced thiols of
CXXCH motif of apocytochrome. Thus, the oxidized HP1227 is
next reduced by the action of HP0377 – CcmG, an H. pylori Dsb
protein involved in cytochrome c biogenesis (Bocian-Ostrzycka
et al., 2015). We also showed that HP0377 reactivates oxidized,
scrambled RNase (scRNaseA; Roszczenko et al., 2015). Since
H. pylori does not possess a classical DsbC, HP0377 may
contribute to the Dsb-related isomerization pathway in vivo and
the close cooperation between HP0231 and HP0377 ensures the
proper protein oxidative folding.
As was shown in this paper, HP0231 prevents the thermal
aggregation of CS and LUC. Recently, it has been shown that
HP0231 acts as folding factor for HcpE, which is consistent with
its chaperone activity (Lester et al., 2015). Similarly to the data
presented by Lester et al. (2015) we found that the lower amount
of HcpC protein is present in the hp0231 isogenic mutant than
in H. pylori wild-type as a consequence of the lack of HP0231
chaperone activity. We also evaluated the inﬂuence of HP0231
on the redox state of the HcpC using AMS trapping strategy.
We showed, that the lack of HP0231 did not change the HcpC
redox state. However, it should be stressed that AMS trapping
experiment does not distinguish between properly folding and
misfolding HP0231. Thus the mechanism of the H. pylori Hcp
oxidation still remains unclear.
The catalytic domains of both dimeric oxidoreducases
(HP0231m and LpDsbA2N) are active in E. coli cells in an
EcDsbB-dependent manner (Kpadeh et al., 2013). However,
HP0231m and LpDsbA2N (a truncated form of the LpDsbA2)
diﬀer in their biochemical properties. In contrast to LpDsbA2N,
HP0231m is not active in the insulin reduction assay, and
additionally, it displays a high chaperone activity. These features
that are untypical for a monomeric DsbA protein may reﬂect
its origin. HP0231 originates from DsbG, the Dsb protein
which is not active in the insulin reduction assay and which
possesses/exhibits chaperone activity. The solved structure
of the HP0231 catalytic domain (HP0231m) conﬁrmed the
phylogenetic analysis and showed that it is similar in structure
to class II DsbA proteins. Members of this class, such as MtDsbA
or SaDsbA (Mycobacterium tuberculosis or Staphylococcus aureus
DsbA, respectively), also are not active in the insulin reduction
assay (Heras et al., 2008; Chim et al., 2013). However, it should
be noted that the HP0231 catalytic domain contains CXXC and
cis-Pro motifs characteristic of class I DsbA proteins (CPHC
and VcP). So far, the dimeric structure of oxidoreductases was
considered to be crucial for their chaperone activity (Zhao
et al., 2003). Thus, our data demonstrating high chaperone
activity for HP0231m are rather unexpected and indicate a
new, still unidentiﬁed mechanism that allows a monomeric Dsb,
which originated from the dimeric DsbG, to act as a molecular
chaperone.
It is still unclear how dimeric Dsb proteins involved in
disulﬁde bond formation are reoxidized in vivo. L. pneumophila
encodes two DsbBs, Actinobacteria does not encode DsbB, and
H. pylori encodes a DsbB-like protein. We showed that activity
of dimeric HP0231 is independent of EcDsbB (in E. coli) and
in H. pylori the lack of DsbI slightly aﬀects its redox state but
doesn’t inﬂuence its function in motility. The mechanism of the
reoxidizing process of HP0231 still needs to be clariﬁed.
Conclusion
Taken together, HP0231 is a unique dimeric oxidoreductase
involved in disulﬁde bond formation. It combines oxidative
functions characteristic of DsbA proteins and chaperone activity
characteristic of DsbC/DsbG, and it lacks isomerization activity.
Those combined untypical features result from its evolutionary
origin, which is noticeable in the structure of its catalytic domain.
Although the mechanism responsible for HP0231 reoxidation
remains to be fully elucidated, we demonstrated that this protein
is present in an oxidized form that is eﬃciently maintained in
native host and E. coli. Moreover, we demonstrated that the
HP0231 dimeric structure is necessary for its interaction with
substrates in the native host.
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